One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Insulin Pumps Global Market

インスリンポンプグローバル市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2028年


[ 英語タイトル ] Insulin Pumps Global Market - Forecast To 2028


Product Code : IQ4IHC00116244
Survey : IQ4I
Publish On : December, 2021
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, Italy and Others), Asia-Pacific (Japan, China, India, and Others), Rest of World (Brazil, Turkey, Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
DEBIOTECH S.A.
INSULET CORPORATION
MEDTRONIC, PLC
MICROTECH MEDICAL INC
F. HOFFMANN-LA ROCHE AG
SOOIL DEVELOPMENT CO. LTD.
TANDEM DIABETES CARE INC.
YPSOMED HOLDINGS AG
ZEALAND PHARMA
ZHENGZHOU PHRAY TECHNOLOGY CO., LTD.
LIST OF COMPANIES MENTIONED IN THE REPORT
CEQUR SA
DEBIOTECH S.A.
EOFLOW
F. HOFFMANN LA ROCHE AG
INSULET CORPORATION
JIANGSU DELFU MEDICAL DEVICE CO., LTD.
LENOMED MEDICAL
MEDTRONIC, PLC
MEDTRUM TECHNOLOGIES
MEDZER
MICROPORT SCIENTIFIC
MICROTECH MEDICAL, INC.
SOOIL DEVELOPMENT
TANDEM DIABETES CARE
TERUMO CORPORATION
VICENTRA B.V.
WUXI APEX MEDICAL
YPSOMED AG
ZEALAND PHARMA (VALERITAS)
ZHENGZHOU PHRAY TECHNOLOGY CO., LTD.

[Report Description]

Insulin pumps are medical devices used for administering insulin in an automated, controlled, and precise manner. These devices are used in the treatment of diabetes mellitus know as continuous subcutaneous insulin infusion (CSII), these insulin systems help in avoiding medical errors which would lead to serious life-threatening circumstances or even sometimes to the death of a patient.
According to IQ4I analysis, the insulin pumps global market is expected to grow at a high single digit CAGR from 2021 to 2028 to reach $6,412.9 million by 2028. The insulin pumps market is segmented based on products, applications, pump utility, end-users and geography. The insulin pumps products market is segmented into insulin pumps and consumables, among them, insulin pumps held the largest share of the market in 2021 and are expected to grow at high single digit CAGR from 2021 to 2028. Insulin pumps are further sub-segmented into tethered insulin pumps and patch insulin pumps, among which the patch pump accounted for the largest share in 2021 and is expected to grow at high single digit CAGR from 2021 to 2028, the tethered pump market is expected to grow at strong CAGR from 2021 to 2028. The applications market is segmented into type 1 diabetes and type 2 diabetes, among them, the type 1 diabetes segment held the largest share in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. The market based on pump utility is segmented into disposable pumps and durable pumps, among which durable pumps command the largest revenue in 2021, the disposable pump segment is expected to grow at high single digit CAGR from 2021 to 2028. The disposable pump market is further sub-segmented into fully disposable and partially disposable pumps, among which, the fully disposable segment commanded the largest revenue in 2021. The end-users market is classified into hospitals, ambulatory surgical centers, homecare and others. Among them, home healthcare commanded the largest share in 2021 and is expected to be the fastest-growing segment with high single digit CAGR from 2021 to 2028.
Geographically, North America is the largest market, with a share followed by Europe and the Asia Pacific. The APAC region is the fastest-growing region and is expected to grow at low teen CAGR from 2021 to 2028 presenting an array of growth opportunities and is likely to get the attention of new investors in the insulin pumps market. Growth in the Asian market is attributed to the rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The insulin pumps market is expected to grow at high single digit CAGR from 2021 to 2028. An increase in the prevalence of diabetes, advantages of insulin pumps in the home care setting, and increasing distribution agreements, partnerships and collaboration activities, is the factors driving the market growth. The increasing product approvals and market expansion in emerging nations are expected to offer potential opportunities.
However, various factors like high cost, inadequate reimbursements, increasing product recalls and privacy concerns and safety issues associated with insulin pumps limit the growth of insulin pumps global market.
The insulin pumps global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Major players in the insulin pumps market include Medtronic PLC (Ireland), Insulet Corporation (U.S.), Tandem Diabetes Care Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Ypsomed Holdings AG (Switzerland), Zealand Pharma (Valeritas) (Denmark), SOOIL development (South Korea), Debiotech S.A. (France), and Microtech Medical, Inc (China).


1 EXECUTIVE SUMMARY 20
2 INTRODUCTION 25
2.1 KEY TAKEAWAYS 25
2.2 SCOPE OF THE REPORT 25
2.3 REPORT DESCRIPTION 26
2.4 MARKETS COVERED 28
2.5 STAKEHOLDERS 29
2.6 RESEARCH METHODOLOGY 29
2.6.1 MARKET SIZE ESTIMATION 31
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 33
2.6.3 SECONDARY SOURCES 34
2.6.4 PRIMARY SOURCES 34
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 35
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 36
2.6.7 ASSUMPTIONS 36
3 MARKET ANALYSIS 40
3.1 INTRODUCTION 40
3.2 MARKET SEGMENTATION 41
3.3 FACTORS INFLUENCING MARKET 43
3.3.1 DRIVERS AND OPPORTUNITIES 44
3.3.1.1 The global rise in the prevalence and incidence of diabetes 44
3.3.1.2 Increase in the use of insulin pumps in-home care settings and disadvantages
of conventional methods over insulin pumps. 45
3.3.1.3 Increasing distribution agreements, partnerships and collaboration activities 46
3.3.1.4 Increase in product approvals 47
3.3.2 RESTRAINTS AND THREATS 47
3.3.2.1 High cost of the continuous subcutaneous insulin infusion therapy (CSII) 47
3.3.2.2 Inadequate reimbursement 48
3.3.2.3 Increased product recalls 49
3.3.2.4 Privacy concern and safety issues associated with insulin pumps 49
3.3.2.5 Stringent regulatory requirements for new products 50
3.4 REGULATORY AFFAIRS 52
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 52
3.4.1.1 ISO:9001: 2015 Quality Management System 52
3.4.1.2 ISO:13485 Medical Devices 52
3.4.2 U.S. 53
3.4.3 CANADA 55
3.4.4 EUROPE 56
3.4.5 INDIA 58
3.4.6 CHINA 59
3.4.7 JAPAN 60
3.5 FUNDING 61
3.6 DEALS 63
3.7 PORTER’S FIVE FORCE ANALYSIS 67
3.7.1 THREAT OF NEW ENTRANTS 68
3.7.2 THREAT OF SUBSTITUTES 69
3.7.3 RIVALRY AMONG EXISTING COMPETITORS 69
3.7.4 BARGAINING POWER OF SUPPLIERS 71
3.7.5 BARGAINING POWER OF BUYERS 71
3.8 CLINICAL TRIALS 72
3.9 SUPPLY CHAIN ANALYSIS 73
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 77
3.10.1 INSULIN PUMPS MARKET SHARE ANALYSIS 77
3.11 MARKET PENETRATION 80
3.11.1 GLOBAL TYPE 1 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS 80
3.11.2 GLOBAL TYPE 2 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS 82
3.11.3 N.A. TYPE 1 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS 84
3.11.4 N.A. TYPE 2 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS 85
3.11.5 E.U. TYPE 1 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS 86
3.11.6 E.U. TYPE 2 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS 87
3.11.7 APAC TYPE 1 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS 88
3.11.8 APAC TYPE 2 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS 89
3.11.9 ROW TYPE 1 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS 90
3.11.10 ROW TYPE 2 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS 91
4 INSULIN PUMPS GLOBAL MARKET, BY PRODUCTS 93
4.1 INTRODUCTION 93
4.2 INSULIN PUMP DEVICES 95
4.2.1 TETHERED INSULIN PUMP 100
4.2.2 PATCH INSULIN PUMP 103
4.3 CONSUMABLES 105
5 INSULIN PUMPS GLOBAL MARKET, BY APPLICATION 111
5.1 INTRODUCTION 111
5.2 TYPE 1 DIABETES 113
5.3 TYPE 2 DIABETES 116
6 INSULIN PUMPS GLOBAL MARKET, BY UTILITY 119
6.1 INTRODUCTION 119
6.2 DURABLE INSULIN PUMP 122
6.3 DISPOSABLE INSULIN PUMP 124
6.3.1 PARTIALLY DISPOSABLE INSULIN PUMP 128
6.3.2 FULLY DISPOSABLE INSULIN PUMP 129
7 INSULIN PUMPS GLOBAL MARKET, BY END-USER 131
7.1 INTRODUCTION 131
7.2 HOSPITALS 134
7.3 AMBULATORY SURGICAL CENTERS 136
7.4 HOME HEALTHCARE 137
7.5 OTHERS 140
8 INSULIN PUMPS GLOBAL MARKET, BY REGION 143
8.1 INTRODUCTION 143
8.2 NORTH AMERICA 146
8.2.1 U.S. 159
8.2.2 REST OF NORTH AMERICA 165
8.3 EUROPE 173
8.3.1 GERMANY 184
8.3.2 FRANCE 189
8.3.3 ITALY 194
8.3.4 REST OF EUROPE 199
8.4 APAC 205
8.4.1 JAPAN 217
8.4.2 CHINA 222
8.4.3 INDIA 227
8.4.4 REST OF APAC 232
8.5 REST OF THE WORLD 237
8.5.1 BRAZIL 250
8.5.2 TURKEY 255
8.5.3 OTHERS 260
9 COMPETITIVE LANDSCAPE 267
9.1 INTRODUCTION 267
9.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 268
9.3 NEW PRODUCT LAUNCH 271
9.4 APPROVAL 274
9.5 ACQUISITION 275
9.6 FUNDING 276
9.7 OTHERS 276
10 MAJOR COMPANIES 278
10.1 DEBIOTECH S.A. 278
10.1.1 OVERVIEW 278
10.1.2 FINANCIALS 279
10.1.3 PRODUCT PORTFOLIO 279
10.1.4 KEY DEVELOPMENTS 279
10.1.5 BUSINESS STRATEGY 279
10.1.6 SWOT ANALYSIS 280
10.2 INSULET CORPORATION 281
10.2.1 OVERVIEW 281
10.2.2 FINANCIALS 282
10.2.3 PRODUCT PORTFOLIO 284
10.2.4 KEY DEVELOPMENTS 285
10.2.5 BUSINESS STRATEGY 286
10.2.6 SWOT ANALYSIS 287
10.3 MEDTRONIC, PLC 288
10.3.1 OVERVIEW 288
10.3.2 FINANCIALS 289
10.3.3 PRODUCT PORTFOLIO 291
10.3.4 KEY DEVELOPMENTS 292
10.3.5 BUSINESS STRATEGY 293
10.3.6 SWOT ANALYSIS 294
10.4 MICROTECH MEDICAL, INC. 295
10.4.1 OVERVIEW 295
10.4.2 FINANCIALS 296
10.4.3 PRODUCT PORTFOLIO 296
10.4.4 KEY DEVELOPMENTS 296
10.4.5 BUSINESS STRATEGY 296
10.4.6 SWOT ANALYSIS 297
10.5 F. HOFFMANN-LA ROCHE AG. 298
10.5.1 OVERVIEW 298
10.5.2 FINANCIALS 299
10.5.3 PRODUCT PORTFOLIO 302
10.5.4 KEY DEVELOPMENTS 303
10.5.5 BUSINESS STRATEGY 304
10.5.6 SWOT ANALYSIS 305
10.6 SOOIL DEVELOPMENT CO. LTD. 306
10.6.1 OVERVIEW 306
10.6.2 FINANCIALS 306
10.6.3 PRODUCT PORTFOLIO 306
10.6.4 KEY DEVELOPMENTS 307
10.6.5 BUSINESS STRATEGY 307
10.6.6 SWOT ANALYSIS 308
10.7 TANDEM DIABETES CARE INC. 309
10.7.1 OVERVIEW 309
10.7.2 FINANCIALS 310
10.7.3 PRODUCT PORTFOLIO 312
10.7.4 KEY DEVELOPMENTS 312
10.7.5 BUSINESS STRATEGY 314
10.7.6 SWOT ANALYSIS 315
10.8 YPSOMED HOLDING AG. 316
10.8.1 OVERVIEW 316
10.8.2 FINANCIALS 317
10.8.3 PRODUCT PORTFOLIO 318
10.8.4 KEY DEVELOPMENTS 319
10.8.5 BUSINESS STRATEGY 320
10.8.6 SWOT ANALYSIS 321
10.9 ZEALAND PHARMA 322
10.9.1 OVERVIEW 322
10.9.2 FINANCIALS 323
10.9.3 PRODUCT PORTFOLIO 323
10.9.4 KEY DEVELOPMENTS 324
10.9.5 BUSINESS STRATEGY 324
10.9.6 SWOT ANALYSIS 325
10.10 ZHENGZHOU PHRAY TECHNOLOGY CO., LTD. 326
10.10.1 OVERVIEW 326
10.10.2 FINANCIALS 326
10.10.3 PRODUCT PORTFOLIO 326
10.10.4 KEY DEVELOPMENTS 326
10.10.5 BUSINESS STRATEGY 327
10.10.6 SWOT ANALYSIS 327

LIST OF TABLES
TABLE 1 INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 23
TABLE 2 TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION, BY REGION (2021) 82
TABLE 3 TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION, BY REGION (2021) 84
TABLE 4 INSULIN PUMPS GLOBAL MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 94
TABLE 5 INSULIN PUMP DEVICES GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 97
TABLE 6 INSULIN PUMP DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2020-2028) ($MN) 98
TABLE 7 TETHERED INSULIN PUMP GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 102
TABLE 8 PATCH INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 104
TABLE 9 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 106
TABLE 10 FEATURES COMPARISON OF SOME OF THE CURRENTLY MARKETED INSULIN PUMPS 108
TABLE 11 INSULIN PUMPS GLOBAL MARKET REVENUE, BY APPLICATION
(2020-2028) ($MN) 112
TABLE 12 TYPE 1 DIABETES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 116
TABLE 13 TYPE 2 DIABETES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 118
TABLE 14 INSULIN PUMPS GLOBAL MARKET REVENUE, BY PUMP UTILITY
(2020-2028) ($MN) 120
TABLE 15 DURABLE PUMP GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 122
TABLE 16 DISPOSABLE PUMP GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 125
TABLE 17 DISPOSABLE PUMP GLOBAL MARKET REVENUE, BY PUMP TYPE
(2020-2028) ($MN) 126
TABLE 18 PARTIALLY DISPOSABLE PUMP GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 128
TABLE 19 FULLY DISPOSABLE PUMP GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 130
TABLE 20 INSULIN PUMPS GLOBAL MARKET REVENUE, BY END-USER
(2020-2028) ($MN) 132
TABLE 21 HOSPITAL GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 135
TABLE 22 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN) 137
TABLE 23 HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 139
TABLE 24 OTHER END-USER GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 141
TABLE 25 INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 144
TABLE 26 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 148
TABLE 27 NORTH AMERICA INSULIN PUMP DEVICES MARKET REVENUE, BY PRODUCT TYPE (2020-2028) ($MN) 149
TABLE 28 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY APPLICATION (2020-2028) ($MN) 151
TABLE 29 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY (2020-2028) ($MN) 153
TABLE 30 NORTH AMERICA DISPOSABLE PUMPS MARKET REVENUE, BY PUMP TYPE (2020-2028) ($MN) 155
TABLE 31 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY END-USER
(2020-2028) ($MN) 156
TABLE 32 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY COUNTRY
(2020-2028) ($MN) 158
TABLE 33 EUROPE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 175
TABLE 34 EUROPE INSULIN PUMP DEVICES MARKET REVENUE, BY PRODUCT TYPE (2020-2028) ($MN) 175
TABLE 35 EUROPE INSULIN PUMPS MARKET REVENUE, BY APPLICATION
(2020-2028) ($MN) 177
TABLE 36 EUROPE INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY
(2020-2028) ($MN) 177
TABLE 37 EUROPE DISPOLSABLE PUMPS MARKET REVENUE, BY PUMP TYPE
(2020-2028) ($MN) 179
TABLE 38 EUROPE INSULIN PUMPS MARKET REVENUE, BY END-USER
(2020-2028) ($MN) 181
TABLE 39 EUROPE INSULIN PUMPS MARKET REVENUE, BY COUNTRY
(2020-2028) ($MN) 183
TABLE 40 APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 207
TABLE 41 APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCT TYPE
(2020-2028) ($MN) 207
TABLE 42 APAC INSULIN PUMPS MARKET REVENUE, BY APPLICATION
(2020-2028) ($MN) 209
TABLE 43 APAC INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY
(2020-2028) ($MN) 211
TABLE 44 APAC DISPOSABLE PUMPS MARKET REVENUE, BY PUMP TYPE
(2020-2028) ($MN) 212
TABLE 45 APAC INSULIN PUMPS MARKET REVENUE, BY END-USER
(2020-2028) ($MN) 214
TABLE 46 APAC INSULIN PUMPS MARKET REVENUE, BY COUNTRY (2020-2028) ($MN) 216
TABLE 47 ROW INSULIN PUMPS MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 238
TABLE 48 ROW INSULIN PUMPS MARKET REVENUE, BY PRODUCTS
(2020-2028) ($MN) 239
TABLE 49 ROW INSULIN PUMPS MARKET REVENUE, BY APPLICATION
(2020-2028) ($MN) 241
TABLE 50 ROW INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY
(2020-2028) ($MN) 243
TABLE 51 ROW DISPOSABLE PUMPS MARKET REVENUE, BY PUMP TYPE
(2020-2028) ($MN) 245
TABLE 52 ROW INSULIN PUMPS MARKET REVENUE, BY END-USER (2020-2028) ($MN) 247
TABLE 53 ROW INSULIN PUMPS MARKET REVENUE, BY COUNTRY (2020-2028) ($MN) 249
TABLE 54 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2020-2021) 268
TABLE 55 NEW PRODUCT LAUNCH (2020-2021) 271
TABLE 56 APPROVALS (2020-2021) 274
TABLE 57 ACQUISITION (2020-2021) 275
TABLE 58 FUNDING (2020-2021) 276
TABLE 59 OTHERS (2020-2021) 277
TABLE 60 INSULET CORPORATION: TOTAL REVENUE AND R&D EXPENSES,
(2019-2021 (Q2)) ($MN) 282
TABLE 61 INSULET CORPORATION: TOTAL REVENUE, BY SEGMENT,
(2019-2021 (Q2)) ($MN) 283
TABLE 62 INSULET CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
(2019-2021 (Q2)) ($MN) 284
TABLE 63 MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES,
(2019-2021) ($MN) 289
TABLE 64 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENT, (2019-2021) ($MN) 290
TABLE 65 MEDTRONIC PLC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN) 291
TABLE 66 F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE AND R&D EXPENSES,
(2019-2021(Q2)) ($MN) 299
TABLE 67 F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE, BY SEGMENT,
(2019-2021 (Q2)) ($MN) 300
TABLE 68 F. HOFFMANN-LA ROCHE AG: DIAGNOSTIC REVENUE, BY SUB-SEGMENT, (2019-2021) (Q2) ($MN) 301
TABLE 69 F. HOFFMANN-LA ROCHE AG: DIAGNOSTIC DIVISION TOTAL REVENUE,
BY GEOGRAPHY, (2019-2021) (Q2) ($MN) 302
TABLE 70 TANDEM DIABETES CARE INC: TOTAL REVENUE AND R&D EXPENSES, (2019-2021 (Q2)) ($MN) 310
TABLE 71 TANDEM DIABETES CARE INC: TOTAL REVENUE, BY SEGMENT,
(2019-2021 (Q2)) ($MN) 311
TABLE 72 TANDEM DIABETES CARE INC: TOTAL REVENUE, BY GEOGRAPHY,
(2019-2021 (Q2)) ($MN) 311
TABLE 73 YPSOMED HOLDINGS AG: TOTAL REVENUE AND R&D EXPENSES,
(2018-2020) ($MN) 317
TABLE 74 YPSOMED HOLDINGS AG: TOTAL REVENUE, BY SEGMENT,
(2018-2020) ($MN) 317
TABLE 75 YPSOMED HOLDINGS AG: TOTAL REVENUE, BY GEOGRAPHY,
(2018-2020) ($MN) 318
TABLE 76 ZEALAND PHARMA: TOTAL REVENUE AND R&D EXPENSES,
(2019-2021)(Q1) ($MN) 323

LIST OF FIGURES
FIGURE 1 INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 24
FIGURE 2 RESEARCH METHODOLOGY: INSULIN PUMPS GLOBAL MARKET 30
FIGURE 3 INSULIN PUMPS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 31
FIGURE 4 INSULIN PUMPS GLOBAL MARKET: FORECASTING MODEL 32
FIGURE 5 INSULIN PUMPS GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION 33
FIGURE 6 INSULIN PUMPS GLOBAL MARKET SEGMENTATION 42
FIGURE 7 MARKET DYNAMICS 43
FIGURE 8 INSULIN PUMPS GLOBAL MARKET: PORTER’S ANALYSIS 68
FIGURE 9 CLINICAL TRIALS OF INSULIN PUMPS 72
FIGURE 10 INSULIN PUMPS GLOBAL MARKET: SUPPLY CHAIN ANALYSIS 73
FIGURE 11 INSULIN PUMPS GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2021 (%) 77
FIGURE 12 GLOBAL TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 81
FIGURE 13 GLOBAL TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 83
FIGURE 14 N.A. TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 85
FIGURE 15 N.A. TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 86
FIGURE 16 E.U. TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 87
FIGURE 17 E.U. TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 88
FIGURE 18 APAC TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 89
FIGURE 19 APAC TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 90
FIGURE 20 ROW TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 91
FIGURE 21 ROW TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 92
FIGURE 22 INSULIN PUMPS GLOBAL MARKET REVENUE, BY PRODUCTS AND PRODUCT TYPE (2021) ($ MN) 99
FIGURE 23 CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2021 V/S 2028) (%) 107
FIGURE 24 INSULIN PUMPS GLOBAL MARKET SHARE, BY APPLICATION
(2021 V/S 2028) (%) 113
FIGURE 25 INSULIN PUMP GLOBAL MARKET SHARE, BY PUMP UTILITY,
(2021 V/S 2028) (%) 121
FIGURE 26 DURABLE PUMP GLOBAL MARKET SHARE, BY REGION,
(2021 V/S 2028) (%) 123
FIGURE 27 DISPOSABLE PUMP GLOBAL MARKET SHARE, BY PUMP TYPE,
(2021 V/S 2028) (%) 127
FIGURE 28 INSULIN PUMPS GLOBAL MARKET SHARE, BY END-USER
(2021 V/S 2028) (%) 133
FIGURE 29 HOSPITALS GLOBAL MARKET SHARE, BY REGION, (2021 V/S 2028) (%) 136
FIGURE 30 HOME HEALTHCARE GLOBAL MARKET SHARE, BY REGION
(2021 V/S 2028) (%) 140
FIGURE 31 OTHER END-USER GLOBAL MARKET SHARE, BY REGION,
(2021 V/S 2028) (%) 142
FIGURE 32 INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) CAGR (%) 145
FIGURE 33 INSULIN PUMPS GLOBAL MARKET SHARE, BY REGIONAL MARKET REVENUE (2021) (%) ($MN) 146
FIGURE 34 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND PRODUCT TYPE (2021) (%) 150
FIGURE 35 NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY APPLICATION
(2021 V/S 2028) (%) 152
FIGURE 36 NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY PUMP UTILITY, (2021 V/S 2028) (%) 154
FIGURE 37 NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY END-USER
(2021 V/S 2028) (%) 157
FIGURE 38 NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY COUNTRY
(2021 V/S 2028) (%) 159
FIGURE 39 U.S. INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND APPLICATION (2021 V/S 2028) ($MN) 162
FIGURE 40 U.S. INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USER (2021 V/S 2028) ($MN) 163
FIGURE 41 U.S. TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 164
FIGURE 42 U.S. TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 165
FIGURE 43 REST OF NORTH AMERICA INSULIN PUMPS MARKET REVENUE,
BY PRODUCT AND APPLICATION (2021 V/S 2028) ($MN) 168
FIGURE 44 REST NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USER (2021 V/S 2028) ($MN) 169
FIGURE 45 CANADA TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 170
FIGURE 46 CANADA TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 171
FIGURE 47 MEXICO TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 172
FIGURE 48 MEXICO TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 173
FIGURE 49 EUROPE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND PRODUCTS TYPE (2021) (%) 176
FIGURE 50 EUROPE INSULIN PUMPS MARKET SHARE, BY PUMP UTILITY,
(2021 V/S 2028) (%) 178
FIGURE 51 EUROPE DISPOLSABLE PUMPS MARKET SHARE, BY PUMP TYPE,
(2021 V/S 2028) (%) 180
FIGURE 52 EUROPE INSULIN PUMPS MARKET SHARE, BY END-USER
(2021 V/S 2028) (%) 182
FIGURE 53 EUROPE INSULIN PUMPS MARKET SHARE, BY COUNTRY
(2021 V/S 2028) (%) 184
FIGURE 54 GERMANY INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN) 186
FIGURE 55 GERMANY INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND
END-USERS (2021 V/S 2028) ($MN) 187
FIGURE 56 GERMANY TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 188
FIGURE 57 GERMANY TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 189
FIGURE 58 FRANCE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN) 191
FIGURE 59 FRANCE INSULIN PUMPS MARKET REVENUE, BY APPLICATION
(2021 V/S 2028) ($MN) 192
FIGURE 60 FRANCE TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 193
FIGURE 61 FRANCE TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 194
FIGURE 62 ITALY INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN) 196
FIGURE 63 ITALY INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND
END-USERS (2021 V/S 2028) ($MN) 197
FIGURE 64 ITALY TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 198
FIGURE 65 ITALY TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 199
FIGURE 66 REST OF EUROPE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN) 202
FIGURE 67 REST OF EUROPE INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USERS (2021 V/S 2028) ($MN) 203
FIGURE 68 REST OF EUROPE TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 204
FIGURE 69 REST OF EUROPE TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 205
FIGURE 70 APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND PRODUCT TYPE (2021) ($MN) 208
FIGURE 71 APAC INSULIN PUMPS MARKET SHARE, BY APPLICATION
(2021 V/S 2028) (%) 210
FIGURE 72 APAC INSULIN PUMPS MARKET SHARE, BY PUMP UTILITY,
(2021 V/S 2028) (%) 212
FIGURE 73 APAC DISPOSABLE PUMPS MARKET SHARE, BY PUMP TYPE,
(2021 V/S 2028) (%) 213
FIGURE 74 APAC INSULIN PUMPS MARKET SHARE, BY END-USER (2021 V/S 2028) (%) 215
FIGURE 75 APAC INSULIN PUMPS MARKET SHARE, BY COUNTRY (2021 V/S 2028) (%) 217
FIGURE 76 JAPAN INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN) 219
FIGURE 77 JAPAN INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND
END-USERS (2021 V/S 2028) ($MN) 220
FIGURE 78 JAPAN TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 221
FIGURE 79 JAPAN TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 222
FIGURE 80 CHINA INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND APPLICATION (2021 V/S 2028) ($MN) 224
FIGURE 81 CHINA INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND
END-USERS (2021 V/S 2028) ($MN) 225
FIGURE 82 CHINA TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 226
FIGURE 83 CHINA TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 227
FIGURE 84 INDIA INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND APPLICATION (2021 V/S 2028) ($MN) 229
FIGURE 85 INDIA INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND
END-USER (2021 V/S 2028) ($MN) 230
FIGURE 86 INDIA TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 231
FIGURE 87 INDIA TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 232
FIGURE 88 REST OF APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND APPLICATION (2021 V/S 2028) ($MN) 234
FIGURE 89 REST OF APAC INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USERS (2021 V/S 2028) ($MN) 235
FIGURE 90 REST OF APAC TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 236
FIGURE 91 REST OF APAC TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 237
FIGURE 92 ROW INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2021) ($MN) 240
FIGURE 93 ROW INSULIN PUMPS MARKET SHARE, BY APPLICATION
(2021 V/S 2028) (%) 242
FIGURE 94 ROW INSULIN PUMPS GLOBAL MARKET SHARE, BY PUMP UTILITY,
(2021 V/S 2028) (%) 244
FIGURE 95 ROW DISPOSABLE PUMPS GLOBAL MARKET SHARE, BY PUMP TYPE,
(2021 V/S 2028) (%) 246
FIGURE 96 ROW INSULIN PUMPS MARKET SHARE, BY END-USER (2021 V/S 2028) (%) 248
FIGURE 97 ROW INSULIN PUMPS MARKET SHARE, BY COUNTRY (2021 V/S 2028) (%) 250
FIGURE 98 BRAZIL INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN) 252
FIGURE 99 BRAZIL INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND APPLICATION (2021 V/S 2028) ($MN) 253
FIGURE 100 BRAZIL TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 254
FIGURE 101 BRAZIL TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 255
FIGURE 102 TURKEY INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN) 257
FIGURE 103 TURKEY INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND
END-USERS (2021 V/S 2028) ($MN) 258
FIGURE 104 TURKEY TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 259
FIGURE 105 TURKEY TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 260
FIGURE 106 OTHERS INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN) 263
FIGURE 107 OTHERS INSULIN PUMPS MARKET REVENUE, BY PUMP UTILIY AND
END-USER (2021 V/S 2028) ($MN) 264
FIGURE 108 OTHERS TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 265
FIGURE 109 OTHERS TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021) 266
FIGURE 110 KEY GROWTH STRATEGIES (2020-2021) 267
FIGURE 111 SWOT: DEBIOTECH S.A. 280
FIGURE 112 SWOT: INSULET CORPORATION 287
FIGURE 113 SWOT: MEDTRONIC, PLC 294
FIGURE 114 SWOT: MICROTECH MEDICAL INC 297
FIGURE 115 SWOT: F. HOFFMANN-LA ROCHE AG. 305
FIGURE 116 SWOT: SOOIL DEVELOPMENT CO. LTD. 308
FIGURE 117 SWOT: TANDEM DIABETES CARE INC 315
FIGURE 118 SWOT: YPSOMED HOLDINGS AG 321
FIGURE 119 SWOT: ZEALAND PHARMA 325
FIGURE 120 SWOT: ZHENGZHOU PHRAY TECHNOLOGY CO., LTD 327

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+